Odyssey Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Odyssey Health generated cash of -$1,215,210, which is more than the previous year. Cash used in financing activities reached the amount of $180,724 last year. Net change in cash is therefore -$34,486.
Cash Flow
| 2015 | 185.83K | 0 | -226.46K |
|---|---|---|---|
| 2016 | -60.85K | -53.31K | 111K |
| 2017 | -116.59K | 0 | 127.84K |
| 2018 | -146.06K | 0 | 133.02K |
| 2019 | -104.83K | 0 | 271.54K |
| 2020 | -649.14K | 0 | 545K |
| 2021 | -3.42M | 0 | 3.91M |
| 2022 | -3.17M | -45.22K | 2.73M |
| 2023 | -1.47M | -10.06K | 1.44M |
| 2024 | -1.21M | 1M | 180.72K |
ODYY Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 36.86K | 72.53K | 556.58K | 62.95K | 167.09K | 390 | 13.42K | 2.18K | 5.35K | 45.98K |
Operating activities | ||||||||||
Net income | -842.31K | -5.91M | -8.44M | -16.88M | -4.34M | -448.42K | -483.11K | -197.84K | -86.11K | -160.69K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.53K | 3.41K | 2.37K | 5.55K | 10.55K | 41.38K | 10.55K | 10.55K | 5.13K | 0 |
Stock-based compensation expense | 577.80K | 2.82M | 3.87M | 2.00M | 2.78M | 101.41K | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 577.80K | 2.82M | 3.87M | 2.00M | 2.78M | 101.41K | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 89.90K | 0 | 0 | 0 | 0 | 0 | 17K | -18.05K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -195.98K | 248.08K | 324.78K | 1.00M | 221.64K | 21.05K | 47.88K | 11.42K | 13.62K | 65.73K |
Cash generated by operating activities | -1.21M | -1.47M | -3.17M | -3.42M | -649.14K | -104.83K | -146.06K | -116.59K | -60.85K | 185.83K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50K | 0 |
Investments In Property Plant And Equipment | 0 | -10.06K | -45.22K | 0 | 0 | 0 | 0 | 0 | -3.31K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 1M | -10.06K | -45.22K | 0 | 0 | 0 | 0 | 0 | -53.31K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 55.62K | 580.22K | 2.46M | 2.93M | 0 | 0 | 50K | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 267.73K | -415.23K | -545K | 271.54K | 0 | 235K | 0 | 0 |
Cash used in financing activities | 180.72K | 1.44M | 2.73M | 3.91M | 545K | 271.54K | 133.02K | 127.84K | 111K | -226.46K |
Net Change In Cash | -34.48K | -35.66K | -484.05K | 493.63K | -104.14K | 166.70K | -13.03K | 11.24K | -3.16K | -40.63K |
Cash at end of period | 2.37K | 36.86K | 72.53K | 556.58K | 62.95K | 167.09K | 390 | 13.42K | 2.18K | 5.35K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |